Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000162510 | SCV000212901 | likely benign | Hereditary cancer-predisposing syndrome | 2015-05-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000988695 | SCV000558435 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000162510 | SCV000682264 | likely benign | Hereditary cancer-predisposing syndrome | 2016-08-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000732576 | SCV000714708 | likely benign | not provided | 2021-03-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 21933854) |
Eurofins Ntd Llc |
RCV000732576 | SCV000860546 | uncertain significance | not provided | 2018-04-10 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988695 | SCV001138519 | likely benign | Ataxia-telangiectasia syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000732576 | SCV001475561 | likely benign | not provided | 2019-12-10 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000162510 | SCV002528431 | likely benign | Hereditary cancer-predisposing syndrome | 2021-01-31 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000732576 | SCV002774251 | likely benign | not provided | 2021-08-18 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589675 | SCV005083946 | benign | Familial cancer of breast | 2024-05-23 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004700498 | SCV005203543 | likely benign | not specified | 2024-07-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004551378 | SCV004784846 | likely benign | ATM-related disorder | 2020-01-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |